These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6156073)

  • 1. Adenosine deaminase specific activity in normal, benign hypertrophied and neoplastic human prostate tissue.
    Tritsch GL; Murphy GP
    Eur Urol; 1980; 6(4):229-31. PubMed ID: 6156073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of normal and mutant forms of human adenosine deaminase - a review.
    Daddona PE; Kelley WN
    Mol Cell Biochem; 1980 Feb; 29(2):91-101. PubMed ID: 6988697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear casein kinase 2 (CK-2) activity in human normal, benign hyperplastic, and cancerous prostate.
    Yenice S; Davis AT; Goueli SA; Akdas A; Limas C; Ahmed K
    Prostate; 1994; 24(1):11-6. PubMed ID: 7507238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of lymphocyte adenosine deaminase activity in patients with renal and transitional cell carcinoma.
    Sufrin G; Tritsch GL; Mittelman A; Murphy GP
    Int Adv Surg Oncol; 1978; 1():11-28. PubMed ID: 399761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adenosine deaminase activity in a transplantable murine renal adenocarcinoma.
    Sufrin G; Tritsch GL; Moore RH; Murphy GP
    Invest Urol; 1979 Mar; 16(5):385-7. PubMed ID: 429136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of human prostatic acid phosphatase and prostate specific antigen genes in neoplastic and benign tissues.
    Sharief FS; Mohler JL; Sharief Y; Li SS
    Biochem Mol Biol Int; 1994 Jun; 33(3):567-74. PubMed ID: 7524903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adenosine deaminase complexing protein (ADCP) expression and metastatic potential in prostatic adenocarcinomas.
    Dinjens WN; Ten Kate J; Kirch JA; Tanke HJ; Van der Linden EP; Van den Ingh HF; Van Steenbrugge GJ; Meera Khan P; Bosman FT
    J Pathol; 1990 Mar; 160(3):195-201. PubMed ID: 1692338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenosine deaminase activity in thymus and other human tissues.
    Adams A; Harkness RA
    Clin Exp Immunol; 1976 Dec; 26(3):647-9. PubMed ID: 1009688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lack of adenosine deaminase deficiency in the mutant mouse wasted.
    Geiger JD; Nagy JI
    FEBS Lett; 1986 Nov; 208(2):431-4. PubMed ID: 3780980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevation of serum prostatic acid phosphatase levels after prostatic massage.
    Wadström J; Huber P; Rutishauser G
    Urology; 1984 Dec; 24(6):550-1. PubMed ID: 6209846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positive correlation between adenosine deaminase activity and superoxide formation during phagocytosis.
    Tritsch GL; Niswander PW
    J Med; 1980; 11(5-6):393-9. PubMed ID: 6300272
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human adenosine deaminase and its binding protein in normal and adenosine deaminase-deficient fibroblast cell strains.
    Daddona PE; Frohman MA; Kelley WN
    J Biol Chem; 1980 Jun; 255(12):5681-7. PubMed ID: 7380831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Adenosine deaminase activity and immune dysfunction (author's transl)].
    Bremer H; Bauer I; Brock J
    Allerg Immunol (Leipz); 1981; 27(1):3-13. PubMed ID: 6455054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paradoxical expression of adenosine deaminase in T cells cultured from a patient with adenosine deaminase deficiency and combine immunodeficiency.
    Arredondo-Vega FX; Kurtzberg J; Chaffee S; Santisteban I; Reisner E; Povey MS; Hershfield MS
    J Clin Invest; 1990 Aug; 86(2):444-52. PubMed ID: 1974554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine deaminase in human epidermis from healthy and psoriatic subjects.
    Koizumi H; Iizuka H; Aoyagi T; Miura Y
    Arch Dermatol Res; 1983; 275(5):310-4. PubMed ID: 6660902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha-methylacyl-CoA racemase (P504S) expression in evolving carcinomas within benign prostatic hyperplasia and in cancers of the transition zone.
    Leav I; McNeal JE; Ho SM; Jiang Z
    Hum Pathol; 2003 Mar; 34(3):228-33. PubMed ID: 12673556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The correlation of adenosine deaminase and purine nucleoside phosphorylase activities in human lymphocytes subpopulations and in various lymphoid malignancies.
    Demeocq F; Viallard JL; Boumsell L; Richard Y; Chassagne J; Plagne R; Lemerle J; Bernard A
    Leuk Res; 1982; 6(2):211-20. PubMed ID: 6821120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of adenosine deaminase and of purine nucleoside phosphorylase in peripheral lymphocytes from patients with acquired immunological disorders.
    Sidi Y; Boer P; Pick I; Pinkhas J; Sperling O
    Biomedicine; 1980 Apr; 33(2):39-41. PubMed ID: 6773594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginase activity in prostatic tissue of patients with benign prostatic hyperplasia and prostatic carcinoma.
    Harris BE; Pretlow TP; Bradley EL; Whitehurst GB; Pretlow TG
    Cancer Res; 1983 Jun; 43(6):3008-12. PubMed ID: 6189588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of 2,6-diamino-9-(2-hydroxyethoxymethyl)purine to acyclovir as catalyzed by adenosine deaminase.
    Spector T; Jones TE; Beacham LM
    Biochem Pharmacol; 1983 Sep; 32(17):2505-9. PubMed ID: 6351865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.